Enjoy complimentary customisation on priority with our Enterprise License!
The antibacterial drugs market size is forecast to increase by USD 7.63 billion at a CAGR of 3.2% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of bacterial infections and the rising potential of nanotechnology in combating these diseases. Topical antibiotics, such as azithromycin and clindamycin, continue to dominate the market, particularly in the treatment of skin infections. Oral antibiotics, including cefdinir, levofloxacin, amoxicillin/clavulanate, and nitrofurantoin, remain popular choices for treating various bacterial infections. However, the development of antibiotic-resistant strains poses a significant challenge to the market, leading to the need for new classes of antibiotics, such as minocycline and sulfamethoxazole, to address this issue. The integration of nanotechnology in antibacterial drugs is expected to revolutionize the industry by improving drug delivery systems and enhancing their efficacy against antibiotic-resistant bacteria.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Drug Class
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.